Alpenglow Biosciences

Seattle, WA · Founded 2018 · Privately Held (backing)

Developer of a microscopy imaging system designed to analyze images of complex and morphological structures of tissue samples. Alpenglow Biosciences is based in Seattle, WA and was founded in 2018. Its last reported valuation was $14.6 million in Jun 2021. It has raised $9.8 million across 1 recorded round; the latest was a $3 million seed round in Mar 2024.

Last reported valuation
$14.6M
Oct 2026
Priced at
—
Total raised
$9.8M
Last round
Seed Round
Mar 2024
What is Alpenglow Biosciences worth?
$14.6Mlast reported valuation · Oct 2026

Alpenglow Biosciences's last reported valuation, Jun 2021. Nothing priced has surfaced since.

Free account
More of Alpenglow Biosciences with a free account
  • ·The complete investor list: 12 names
  • ·Watch Alpenglow Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Alpenglow Biosciences funding history

1 rounds
DateRoundRaisedPost-money
Mar 2024Seed Round$3.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Alpenglow Biosciences valuation

Alpenglow Biosciences's last reported valuation was $14.6 million in Jun 2021. No priced round, secondary trade or fund mark has surfaced since.

How much has Alpenglow Biosciences raised?

Alpenglow Biosciences has raised $9.8 million in total; 1 of its rounds is on record. The largest on record was a $3 million seed round in Mar 2024.

Alpenglow Biosciences has filed 1 Form D with the SEC, most recently in Mar 2024 ($1.8 million sold to 4 investors).

How Alpenglow Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Alpenglow Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Alpenglow Biosciences

What is Alpenglow Biosciences worth?
Alpenglow Biosciences is valued at $14.6M as of Oct 2026. Alpenglow Biosciences's last reported valuation, Jun 2021. Nothing priced has surfaced since.
How much has Alpenglow Biosciences raised?
Alpenglow Biosciences has raised $9.8M in total funding across 1 recorded rounds.
When did Alpenglow Biosciences last raise?
Alpenglow Biosciences last raised in Mar 2024 (Seed Round), raising $3.0M.